血清响应因子转化后修饰的最新进展及其在心血管和神经疾病中的治疗潜力
Alexander Visconti1, Hongyu Qiu2
1Cardiovascular Translational Research Center, Department of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, USA.
Vascular pharmacology
|August 29, 2024
概括
血清响应因子 (SRF) 的翻译后修改 (PTMs) 对其功能至关重要,并且与疾病有关. 准SRF PTM为SRF相关疾病提供了一个有前途的治疗策略.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 血清反应因子 (SRF) 是一个重要的转录因子,调节细胞功能.
- 异常的SRF活动和突变与各种疾病有关.
- 翻译后修改 (PTMs) 极大地影响了SRF功能和疾病的发病.
研究的目的:
- 审查了解SRF PTM及其监管机制的最新进展.
- 探索SRF-PTMs在心血管和神经疾病中的作用.
- 突出针对SRF PTM的治疗潜力.
主要方法:
- 关于SRF PTM的最新研究的文献综述.
- 对管理SRF PTMs的监管机制的分析.
- 检查SRF-PTM在疾病背景中的影响.
主要成果:
- PTM对于调节不同细胞类型的SRF活动至关重要.
- 特定的SRF PTM与心血管和神经系统疾病的发病有关.
- 针对SRF PTMs提供了一个新的治疗途径.
结论:
- 在生理过程和疾病发展中,SRF PTM 起着重要的作用.
- 了解SRF PTM可以提高对疾病机制的了解.
- SRF PTM为开发新的治疗策略提供了有希望的目标.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404


